Xcout Intel
Procyrion
Procyrion, Inc. is a Houston, Texas-based heart pump developer. The company focuses on the research, expansion, and development of its Aortix circulatory support device for investigational use.
Subscribe to see Procyrion’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Procyrion at a glance
Procyrion is a medical devices company headquartered in United States. Its most recent funding round, Series E, raised $57.7M in February 2024. Xcout tracks 4 named people at Procyrion, including Eric S Fain (President and Chief Executive Officer).
Procyrion leadership
- Eric S FainPresident and Chief Executive Officer
- Andrew DavisChief Commercial Officer
- Gary F. BurbachChair of the Board of Directors
- Lucas BuchananBoard of Directors
Procyrion funding rounds
The 4 most recent:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series E | $57.7M | 4 named | |
| — | $30M | 4 named | |
| SEC Form D filing | $16M | — | |
| Series B | $10M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Procyrion competitors
A few of Procyrion's closest competitors — see the full list of competitors and alternatives →
Corvion Inc., formerly known as EverHeart Systems, is headquartered in Webster, Texas, and develops fully implanted mechanical circulatory support devices. Its flagship product, the Corvion LVAD, is designed to serve as a successful circulatory support device for severe heart failure.
BrioHealth Solutions develops medical technology for the treatment of advanced heart failure. The company's primary product is the BrioVAD system, an investigational Left Ventricular Assist System (LVAS) designed to improve the quality of life for heart failure patients.
Axon Therapies Inc. is a medical device and biotechnology company headquartered in Santa Clara, California, focused on developing treatments for heart failure.
Alleviant Medical, Inc. is a medical device and clinical trial company headquartered in Austin, Texas, focused on heart failure solutions.
Get Procyrion's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Procyrion in Xcout Intel
- 4 named people with titles, LinkedIn and board committees
- 6 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access